Case reportCalcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: Report of a case
References (13)
- et al.
Osteoarthritis and internal derangement of the temporomandibular joint: A light microscopic study
J Oral Maxillofac Surg
(1986) - et al.
Osteoarthrosis as the cause of craniomandibular pain and dysfunction: A unifying concept
J Oral Maxillofac Surg
(1989) - et al.
Unilateral condylar hyperplasia combined with synovial chondromatosis of the temporomandibular joint. Report of a case
J Maxillofac Surg
(1985) - et al.
Synovial chondromatosis of the temporomandibular joint: A light and electron microscopic study
Oral Surg Oral Med Oral Pathol
(1988) - et al.
Destructive calcium pyrophosphate dihydrate temporo-mandibular arthropathy (pseudogout)
Int J Oral Maxillofac Surg
(1987) - et al.
The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: The “pseudogout syndrome.” I. Clinical aspects
Ann Intern Med
(1962)
Cited by (38)
A case of deposition of calcium pyrophosphate dehydrate crystals with synovial chondromatosis in the temporomandibular joint
2022, Journal of Oral and Maxillofacial Surgery, Medicine, and PathologyCitation Excerpt :There have been previous reports of coexistence of CPPDd and SC, no recurrent cases have been reported [6,18]. However, there have been reports of recurrence of CPPDd and SC alone, which suggests that accumulation of cases and longer-term follow-up is necessary [19–22]. There are many anatomically important structures around the TMJ that are at high risk of damage.
Calcium pyrophosphate dihydrate crystal deposition of the temporomandibular joint: A case report and review of the literature
2019, Journal of Oral and Maxillofacial Surgery, Medicine, and PathologyCitation Excerpt :In the current case, we were able to differentiate CPPDd from other diseases, because the peaks corresponded with those of calcium pyrophosphate dihydrate (Fig. 7). To the best of our knowledge, 49 cases of CPPDd in the TMJ region have been reported [2,6,8,10–45]. The clinical features of the previously published cases and the current case are summarized in Table 1.
Tophaceuos calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint: The preferential site?
2012, Journal of Oral and Maxillofacial SurgeryCitation Excerpt :A total of 54 studies reporting on CPPD in the TMJ, with a total of 57 patients were included. The total number of cases was 58, including our patient.9,10,16-63 The PubMed search for tophaceous CPPD without the limitation of TMJ added an additional 48 patients.8,9,64-96
Nontender mass in the parotid region
2002, Journal of Oral and Maxillofacial SurgeryCitation Excerpt :Synovial fluid levels of inorganic pyrophosphate are higher than plasma levels in these patients, suggesting a local origin of pyrophosphate. The chondrocytes are thought to be the overproducers because the crystals are first seen at the lacunar margin of these cells,7 and it seems evident that an abnormal cartilage matrix predisposes to crystal nucleation. The inflammation is likely initiated by crystals shedding from the synovial membrane.
Tumoral calcium pyrophosphate dihydrate crystal deposition crystal deposition disease
2001, Pathology Research and PracticeCalcium pyrophosphate dihydrate crystal deposition disease in the temporomandibular joint: Diagnostic difficulties and clonal chromosome aberrations in a case followed up for 5 years
2001, Journal of Oral and Maxillofacial Surgery
- ∗
Orofacial Research Group, Department of Oral and Maxillofacial Surgery.
- †
Associate Professor, Department of Oral and Maxillofacial Surgery.